INTRODUCTION
tube gives rise to muscle precursors that form the myotome, the origin of the vertebral and back muscles. Cells from the ventrolateral edge of the dermamyotome migrate out There has been dramatic progress in recent years toward to form the muscles of the limbs and body wall. understanding the molecular mechanisms that regulate Cardiac muscle arises from cells in the anterior lateral skeletal muscle development. In contrast, relatively little plate mesoderm, which become committed to a cardiogenic is known of the mechanisms that give rise to cardiac and fate soon after gastrulation. These precardial cells give rise smooth muscle during embryogenesis. These different musto a heart tube, which undergoes looping, followed by forcle cell types express many of the same muscle-specific mation of the atria and ventricles. genes. However, they are each unique in several respects, In contrast to skeletal and cardiac muscle, which arise including the spectrum of muscle isoforms expressed, morfrom distinct populations of mesodermal precursors, phology, contractile properties, and ability to divide. In prinsmooth muscle arises throughout the embryo from different ciple, the expression of muscle genes in skeletal, cardiac, populations of mesenchymal cell precursors, as well as from and smooth muscle cells could be controlled by a shared the neural crest . Among the three major myogenic regulatory program, which is modified within muscle cell types, the least is known about the mechanisms each lineage to confer the unique identities of each muscle that control muscle gene expression in smooth muscle cells. cell type. Alternatively, there could be myogenic regulatory factors unique to each myogenic lineage, which act through different cis-acting DNA sequences to activate muscle structural genes. This review will consider recent evidence
Regulation of Muscle Differentiation by Myogenic
that suggests the existence of a common myogenic program, bHLH Proteins controlled by the myocyte enhancer factor-2 (MEF2) family Much of our knowledge of skeletal muscle development of MADS box transcription factors.
has come from the discovery of the MyoD family of basic helix-loop-helix (bHLH) proteins, which can activate skele-
Embryonic Origins of the Three Muscle Cell Types
tal muscle gene expression when expressed ectopically in nonmuscle cell types (reviewed in Weintraub During vertebrate embryogenesis, skeletal, cardiac, and et al., 1991; Rudnicki and Jaenisch, 1995) . There are four smooth muscle cells arise from distinct mesodermal precurmembers of this family in vertebrate species, MyoD, Myosors in different regions of the embryo (Fig. 1) . Skeletal musgenin, Myf5, and MRF4, which share extensive amino acid cle is derived from the somites, which form by segmentahomology within their bHLH regions. During embryogenetion of the paraxial mesoderm lateral to the neural tube sis, the myogenic bHLH factors show overlapping, but dis- (Wachtler and Christ, 1992) . The somites appear initially as tinct, expression patterns in the skeletal muscle lineage. epithelial spheres, which subsequently become compartMyf5 is the first member of the family to be expressed in the mentalized to form the dermamyotome and the sclerotome. mouse, appearing in the dorsomedial region of the rostral The region of the dermamyotome adjacent to the neural uncompartmentalized somites beginning at Day 8.0 post coitum (p.c.) . Myogenin is expressed in the myotome about a half-day later and MRF4 and MyoD are expressed begin-
The MEF2 Family of MADS Box Transcription Factors
MEF2 was first identified as a DNA binding activity that recognized an A/T-rich element in the muscle creatine kinase (MCK) enhancer that was essential for full enhancer activity (Gossett et al., 1989) . Subsequently, MEF2 sites have been found in the promoters and enhancers of the majority of skeletal and cardiac muscle structural genes (Braun et al., 1989; Ianello et al., 1991; Wentworth et al., 1991; Zhu et al., 1991; Nakatsuji et al., 1992; Navankasattusas et al., 1992; Muscat et al., 1992; Morisaki and Holmes, 1993; Hidaka et al., 1993; Molkentin and Markham, 1993; Wang et al., 1994; Li and Capetanaki, 1994; Parmacek et al., 1994) . The cloning of genes encoding MEF2 factors (also called RSRFs, for related to Serum Response Factors) revealed that these proteins belong to the MADS box family of transcription factors, named for the first four factors in which this domain was identified: MCM1, which regulates mating type-specific genes in yeast, Agamous and Deficiens, which act as homeotic factors that control flower development, and Serum Response Factor, which controls seruminducible and muscle-specific gene expression (Pollock and Treisman, 1991) . Four mef2 genes, referred to as mef2A-mef2D, have been identified in vertebrate species (Pollock and Treisman, 1991; Yu et al., 1992; Martin et al., , 1994 Breitbart et al., 1993; McDermott et al., 1993; et al., 1993; Chambers et al., 1994; Wong et al., 1994) . There is also a single mef2 gene in Drosophila Nguyen et al., 1994; Taylor et al., 1995) and in Caenorhabditis elegans (M. Krause, personal communication). The Buckingham, 1992) . The roles of these factors in muscle MEF2 proteins share greater than 80% amino acid homoldevelopment have been confirmed by gene knockout experiogy within the 56-amino-acid MADS box at their amino ments, which have shown that MyoD and Myf5 play reduntermini (Fig. 2) . Adjacent to the MADS box is a 29-aminodant roles in the generation of myoblasts, whereas Myoacid domain, called the MEF2 domain, that is not present genin directs myoblast differentiation  in other MADS box proteins. Rudnicki et al., 1992 Rudnicki et al., , 1993 Hasty et al., 1993; Nabeshima The MADS box mediates DNA binding and dimerization et al., 1993; Olson and Klein, 1994) . MRF4 is expressed (reviewed in Shore and Sharrocks, 1995) . Consistent with the late in muscle differentiation and may share functions with homology among MADS box proteins, different members of Myogenin (Zhang et al., 1995) . Because the myogenic bHLH this family recognize similar A/T-rich DNA sequences. Howproteins are not expressed in cardiac or smooth muscle, ever, the consensus sequence for MEF2 binding, YTA(A/ other regulators must control muscle gene expression in T)4TAR, is distinct from the binding sites of other MADS box these cell types.
proteins. The binding sites for MEF2 and other MADS box The myogenic bHLH proteins activate muscle gene exproteins exhibit dyad symmetry, allowing each component of pression by binding to the consensus sequence CANNTG the dimeric DNA binding complex to recognize half of the (N, any nucleotide) as heterodimers with ubiquitous bHLH binding site. Mutagenesis of several MADS box proteins inproteins, known as E-proteins (Murre et al., 1989) . This cluding MEF2 has shown that DNA binding requires the 56-DNA sequence, referred to as an E-box, is found in the amino-acid MADS box, in addition to an extension of about control regions of many but not all skeletal muscle genes 30 amino acids on the carboxyl-terminal side of the MADS (Hauschka, 1994) . While E-boxes are required for transcripbox, which is unique to each subclass of MADS box proteins tional activation of many skeletal muscle genes, they are (Pollock and Treisman, 1991; Molkentin and Olson, 1995) . not by themselves sufficient and depend on adjacent binding
The three-dimensional structure of the MADS box has not sites of other factors to activate skeletal muscle gene tranyet been elucidated. However, sequence specificity of DNA scription. MEF2 binding sites are often associated with Ebinding has been shown to be mediated by basic residues boxes in muscle gene regulatory regions and have been that lie on the same side of a predicted a-helix at the aminoshown to be required for transcriptional activation of those terminal end of the MADS box. Replacing these 28 aminoterminal residues of the MADS box of SRF with those of genes in skeletal muscle cells. MEF2A alters the DNA binding specificity of SRF to that of on which factor is bound at the site. The MEF2 site in the myosin light chain-2 (mlc-2) gene promoter also binds a tissue-MEF2 .
MEF2A, MEF2C, and MEF2D bind the same DNA serestricted zinc finger protein (HF-1b), which appears to play an important role in transcriptional activation (Zhu et al., quence, but subtle differences in binding affinity have been observed among these MEF2 factors, suggesting that their non-1993), and a serum-inducible cardiac-specific factor, BBF-1 (Zhou et al., 1993) . conserved residues may affect their binding properties. DNA sequences surrounding the core consensus sequence also af-MEF2 factors can homo-and heterodimerize, but they do not interact with other known MADS box factors (Pollock fect DNA binding (Yu et al., 1992) . MEF2B fails to bind the MEF2 consensus sequence as a homodimer in vivo or in vitro and Treisman, 1991) . Dimerization of MEF2 is mediated by a hydrophobic stretch of amino acids toward the C-terminal (Pollock and Treisman, 1991; Yu et al., 1992) . However, binding activity is observed with a deletion mutant of MEF2B end of the MADS box, which is predicted to adopt a b-strand conformation. The MEF2 domain is also required for efficient containing only the MADS and MEF2 domains, suggesting that the carboxyl-terminal region of MEF2B inhibits DNA DNA binding, but it does not affect DNA sequence recognition (Molkentin et al., 1995) . Most likely, this region confers binding. Intriguingly, MEF2B activates transcription through the MEF2 site in transfected cells, which raises the possibility dimerization specificity and influences the orientation of the DNA binding domains of the heterodimeric partners. that it may have a unique partner in vivo or that it potentiates the activity of other MEF2 factors.
The carboxyl termini of MEF2A, MEF2C, and MEF2D have been shown to function as transcription activation domains The MEF2 binding site also binds several factors in addition to MEF2, which in principle can allow for regulation of gene (Wong et al., 1994; Martin et al., 1994; Molkentin et al., 1995) . Mutations in this region of the Drosophila MEF2 protein reexpression through competition for DNA binding. In the core of the MCK enhancer, for example, is a low-affinity MEF2 site sult in partial loss-of-function alleles (Ranganayakulu et al., 1995; discussed below) . The mef2A, mef2C, and mef2D genes that is essential for enhancer activity in skeletal and cardiac muscle cells. This site also binds the paired-like homeodogive rise to multiple proteins by alternative splicing within the transcription activation domain, with certain exons being main protein MHox and the POU domain protein Oct-1. Mutational analysis of this site has shown that it must be bound muscle-specific and others being ubiquitous. Heterodimerization among different MEF2 proteins and different splice variby MEF2 for enhancer activity in muscle cells . Since occupancy of this site by these three factors is ants can in principle result in greater than 100 different heterodimeric complexes that recognize the same DNA sequence. mutually exclusive, the activity of the enhancer is dependent It remains to be determined how the different splice variants lational control might be mediated by the untranslated regions of MEF2 mRNAs because exogenous MEF2 tranmight differ functionally.
scripts lacking sequences from the 5 and 3 untranslated regions are translated in fibroblasts, in which endogenous
Regulation of MEF2 Expression
MEF2 transcripts are not efficiently translated. The high degree of sequence conservation of the untranslated regions During mouse embryogenesis, the mef2 genes are expressed in precursors of the three myogenic lineages and of MEF2 mRNAs also suggests that they may play a regulatory role. their descendants. mef2C is the first member of the family to be expressed, appearing in the precardiac mesoderm at Day 7.5 p.c. . Soon thereafter, the
A Mutually Reinforcing Network of Myogenic
other mef2 genes are expressed in the developing heart and Factors the expression of cardiac muscle structural genes ensues. All of the embryonic expression studies have been perThe cell type distribution of MEF2 DNA binding activity has been the subject of much debate. While numerous studformed with probes that do not distinguish between the different exons of the mef2 genes. Expression patterns of ies have documented that MEF2 is highly enriched in differentiated muscle cells ; Muscat et muscle-specific and ubiquitous exons of the various mef2 genes remain to be determined. The expression of mef2C Hidaka et al., 1993; McDermott et al., 1993; Molkentin and Markham, 1993) , others have reported that it is in the cardiac muscle lineage co-incides with the expression of the cardiac homeobox gene Nkx-2.5/csx (Lints et al., ubiquitous (Horlick et al., 1990; Pollock and Treisman, 1991; Han et al., 1992) . The basis for these discrepancies is 1993; Komuro and Izumo, 1993) . A homologue of this gene called tinman has been identified in Drosophila, where it unclear. Consistent with the enrichment of MEF2 activity in muscle cells, reporter genes linked to multimerized is required for formation of the dorsal vessel, which is analogous to the heart (Bodmer, 1995). The coexpression of MEF2 MEF2 sites are preferentially expressed in differentiated myocytes (Gossett et al., 1989; Yu et al., 1992) . The mechaand this homeodomain protein in the early heart is especially intriguing in light of the cooperation between MADS nisms that regulate MEF2 expression during myogenesis have also been controversial. Gossett et al. (1989) reported and homeodomain proteins in other systems (see below) and suggests the possibility of direct interactions between that protein synthesis was required for the upregulation of MEF2 DNA binding activity that accompanies myoblast these proteins.
In the skeletal muscle lineage, MEF2C is expressed in the differentiation, whereas Buchberger et al. (1994) reported that MEF2 activity was induced in the presence of cyclohexsomite myotome a few hours after Myogenin, making it unlikely that MEF2 is required for the genesis of myoblasts imide. During differentiation of skeletal myoblasts in vitro, the or for the initial activation of myogenin gene expression . As in the cardiac muscle lineage, different MEF2 proteins accumulate sequentially. MEF2D has been reported to be expressed first in myoblasts, but the other mef2 genes are expressed in the skeletal muscle lineage after mef2C. mef2 gene expression is also observed it apparently does not activate muscle target genes until myoblasts exit the cell cycle (Breitbart et al., 1993) . The in smooth muscle cells throughout the mouse embryo, where it precedes the expression of muscle structural genes.
mechanisms that repress MEF2D activity in myoblasts remain to be determined. Following initiation of the differenBy about Day 14 p.c. of mouse embryogenesis, mef2 transcripts begin to appear in a variety of nonmuscle cell types tiation program by withdrawal of serum, MEF2A protein accumulates. MEF2C protein does not appear until late in and by birth, mef2A, mef2B, and mef2D are expressed ubiquitously, except in the brain, where they show highly localterminally differentiated myotubes (McDermott et al., 1993; . These sequential expression patized expression patterns (Lyons et al., 1995) . mef2C expression remains restricted to skeletal muscle, brain, and spleen terns of the MEF2 factors during myogenesis are reminiscent of the expression patterns of the myogenic bHLH proin adults. Within the developing brain, expression of the mef2 genes follows gradients of neuronal differentiation.
teins. MEF2 binding activity can be induced in nonmuscle cells One of the perplexing aspects of MEF2 regulation is the disparity between the expression of MEF2 mRNAs and proby forced expression of myogenic bHLH factors . This upregulation occurs in teins. MEF2A, MEF2B, and MEF2D transcripts are expressed in a wide range of adult tissues and established cell 10T1/2 fibroblasts in which the complete myogenic program is induced, as well as in CV-1 cells, which are refraclines, but MEF2 protein and DNA binding activity are largely restricted to differentiated muscle cells and neurons.
tory to myogenic conversion. These findings led to the initial conclusion that MEF2 was present in a regulatory pathThe most likely explanation for this disparity is the existence of a mechanism for translational repression of MEF2 way ''downstream'' of myogenic bHLH proteins. However, it was recently reported that forced expression of MEF2A in mRNAs in cell types in which the protein is undetected. Indeed, translation control of MEF2A expression has refibroblasts can activate expression of Myogenin and MyoD, resulting in formation of multinucleate myotubes and muscently been demonstrated in vascular smooth muscle cells (Suzuki et al., 1995) . There is evidence to suspect that transcle differentiation (Kaushal et al., 1994) . Buchberger et al., 1994) . This site is pathway, but rather by two classes of regulators that regualso required for expression of a myogenin-lacZ transgene late each others' expression in a mutually reinforcing reguin the limb buds and somites of transgenic mice (Cheng et latory network (Fig. 3) . It should be pointed out that other al., 1993; Yee and Rigby, 1993) . In the absence of this site, investigators have been unable to demonstrate stable contransgene expression in the limb buds and the dorsal regions version of fibroblasts to differentiated muscle cells by forced of the somites is lost. However, myogenin transcription in expression of MEF2 (J. Martin, T. Firulli, and E. Olson, un- the ventral regions of the somites does not require the MEF2 published). The basis for these differences is unclear.
site. These results suggest that Myogenin is expressed in The ability of MEF2 factors to regulate muscle gene extwo distinct populations of muscle cells; one of which repression has also been examined in the Xenopus animal quires MEF2 and the other of which is independent of MEF2, cap system. Animal pole cells from blastula stage embryos for expression of myogenin. The existence of two populanormally differentiate as ectoderm and neural tissues. Spections of somitic muscle cell precursors has also been demification of the developmental fate of these cells can be onstrated by somite transplantation experiments (Ordahl changed by exposure to growth factors that induce the difand Le Douarin, 1992). It is possible that the myogeninferentiation of mesodermal derivatives, such as muscle. AllacZ transgene containing a mutated MEF2 site is able to though forced expression of MEF2D in animal caps was distinguish between these two populations. Because MEF2 unable to induce expression of endogenous myogenic bHLH gene expression is initiated after myogenin expression in genes, activation of the endogenous cardiac-specific gene the somites and limb buds, it is likely that MEF2 particimlc-2 was detected in isolated animal pole explants dispates in an indirect autoregulatory loop to amplify and sected from early blastula stage embryos that were injected maintain myogenin gene expression, rather than initially as fertilized eggs with synthetic MEF2D transcripts (Chamactivating myogenin expression (Fig. 3) . bers et al., 1994) . This result is consistent with the expres-MEF2 has also been shown to regulate expression of the sion of MEF2D in cardiac muscle cell precursors and supXenopus MyoDa gene. In this case, a consensus MEF2 bindports a role for MEF2 in the differentiation of cardiac muscle ing site overlaps precisely with the XMyoDa TATA box, cell lineages. Expression of the mlc-2 gene was activated the binding site for the multisubunit transcription factor by ectopic expression of MEF2D but not by expression of TFIID . Binding of both factors to the MEF2A, suggesting that functional differences exist bespecialized TATA motif is required since transactivation is tween members of the MEF2 protein family.
abolished by promoter mutations that selectively prevent binding of either factor. Activation of the XMyoDa pro-
MEF2 Factors Regulate Some Myogenic bHLH
moter by MEF2 requires only the MADS/MEF2 domains;
Genes
this activation is independent of a region toward the Cterminus of MEF2 which is required to activate transcripSeveral recent studies have revealed a role for MEF2 in the regulation of the myogenic bHLH genes. The myogenin tion of promoters with separate binding sites for MEF2 and TFIID (Wong et al., 1994 , 1994) . Within the conserved region of the gene, the positions of D-mef2 introns map to the same codons as exclusive. In the latter case, prior binding of MEF2 might prevent inactivation of the promoter by chromatin assemin the mammalian mef2 genes. Thus, this structural and functional conservation suggests that the Drosophila and bly or other inhibitory events. Because activation of XMyoD expression precedes that of MEF2 in early Xenopus emmammalian mef2 genes evolved from a common ancestral gene more than 600 million years ago. bryos, MEF2 appears to function downstream of XMyoD in the myogenic pathway. The binding of MEF2 to the XMy-D-mef2 is expressed during embryogenesis in a profile that is strikingly similar to the MEF2 expression patterns oDa TATA box might constitute a simple and direct mechanism for stabilizing and amplifying XMyoDa expression in observed in early mouse development. Gene transcripts are first detected in cells of the ventral furrow in the late blastodifferentiating muscle cells. MyoD genes from other species appear to be regulated by different mechanisms than Xmyderm/early gastrula and are restricted to the mesodermal cell layer during germ band extension ; oDa, since the mouse and chicken myoD genes do not contain MEF2 sites in their proximal promoters (Tapscott et Nguyen et al., 1994; Taylor et al., 1995) . During the reorganization of the mesoderm during stage 10 and thereafter al., 1992; Dechesne et al., 1994) .
Binding of MEF2 to the TATA boxes of muscle-specific (Bate, 1993) , there is a dynamic pattern of D-mef2 expression in the external and internal mesoderm cell layers and genes may explain the observation that certain muscle genes require a specific TATA box for expression. Overlapin the precursors of the heart. During germ band retraction and dorsal closure of the embryo, the muscles of the body ping binding sites for MEF2 and TBP are present in the promoters of the mouse and rat MRF4 genes (Naidu et al.,
wall, gut, and heart are formed. D-mef2 transcripts are present in all of these muscle types during their differentiation 1995; Black et al., 1995) . Since MEF2 can also transactivate the MRF4 promoter upon binding to the TATA box, this into the final muscle structures. Immunolocalization experiments using a D-MEF2 antibody shows the expression of architecture appears to be biologically meaningful rather than fortuitous. The presence of overlapping binding sites a nuclear protein that faithfully follows the accumulation of D-mef2 RNA in the mesoderm, muscle cell lineages, and for MEF2 and TBP is not restricted to the promoters of myogenic regulatory genes. The myoglobin gene is effidifferentiated muscles (Fig. 4) Bour et al., 1995) . ciently expressed in muscle cells only with its native TATA box, but not when that sequence is replaced with the TATA There is a lack of D-mef2 expression in twist mutant embryos and expression is severely reduced in snail mutant box of the SV40 promoter (Wefald et al., 1990) . The myoglobin TATA box has been recently shown to bind MEF2 embryos, implicating these two transcription factors as probable regulators of early D-mef2 expression (Lilly et al., (Grayson et al., 1995) . Analogous situations exist with the chick b-globin gene promoter, which is activated by binding 1994; Nguyen et al., 1994) . D-mef2 appears to be a direct target of the Twist protein as ectopic expression of a twist of the erythroid-specific protein cGATA-1 to the TATA motif (Fong and Emerson, 1992) and the pituitary specific regucDNA in the epidermis under the control of a heat shock promoter results in the expression of D-mef2 RNA in the latory gene PIT-1/GHF-1 TATA box, which binds a pituitary-specific factor (McCormick et al., 1990) . These and same cells (Taylor et al., 1995) . Intriguingly, D-mef2 is coexpressed with tinman in the ventral furrow, undifferentiated other examples are illustrative of a general control mechanism involving the direct interaction of regulatory factors mesoderm, and cardiac muscle lineage in the Drosophila embryo, just as the mammalian homologues of these genes with specialized TATA boxes.
are coexpressed in the precardiac mesoderm in the mouse embryo. However, the early mesodermal expression of D-
Genetic Analysis of MEF2 Function in Drosophila
mef2 is independent of tinman Nguyen et al., 1994) . In the future, it will be especially interesting Given the overlapping expression patterns and possible redundancy of the vertebrate MEF2 genes, it may be difficult to determine the mechanisms that regulate D-mef2 expression in the mesoderm and three myogenic lineages. Prelimito address their functions by gene targeting without simultaneously inactivating multiple loci. However, the genetic nary analyses of D-mef2 regulatory sequences in Drosophila germline transformant lines have identified separable entors tinman and bagpipe, which are required for the formation of the heart and visceral muscle (Azpiazu and Frasch, hancer elements that properly drive the expression of a lacZ reporter gene in cells of the ventral furrow, mesoderm, and 1993; Bodmer, 1993) , are expressed correctly in mutant embryos. The formation of the somatic musculature in Drosomatic, visceral, and cardiac muscle lineages C. Chromey, G. Ranganayakulu, B. Zhao, E. Olson, sophila is believed to occur by the fusion of founder cells with fusion-competent myoblasts (Rushton et al., 1995) . and R. Schulz, unpublished).
To address the possible functions of D-mef2 in mesoderm Markers for the founder cells, such as the MyoD homolog nautilus (Michelson et al., 1990; Paterson et al., 1991) and differentiation and muscle development, P element insertional and ethyl methane sulfonate (EMS) chemical mutathe homeobox genes S59 (Dohrman et al., 1990) and apterous (Bourgouin et al., 1992) , are expressed in their normal genesis screens have been carried out to recover lethal mutations in the gene. Embryos homozygous for a P-elementpattern in D-mef2 mutant embryos. Thus, the phenotype of the D-mef2 deficiency embryos suggests that the gene induced 25-kb chromosome deletion that removes essential D-mef2 regulatory sequences express the D-MEF2 protein acts at a relatively late stage within the different myogenic lineages to control cell differentiation (Fig. 5) . at very low levels and fail to form normal differentiated muscles . The use of molecular markers A more detailed understanding of the role of D-mef2 in muscle cell differentiation was obtained through the analyfor the precursors of the somatic, visceral, and cardiac muscles showed that muscle precursor cells were specified and sis of mutants containing point mutations in the gene. The phenotypic analysis of embryos homozygous for EMS-inpositioned normally. For example, the mesodermal regula-
FIG. 5. Myogenic lineages in Drosophila.
Schematic representation of the three myogenic lineages from Drosophila and the genes that are expressed in those lineages. D-mef2 and tinman are coexpressed in the uncommitted mesoderm; both genes are dependent on twist and snail for expression. The prospective mesoderm gives rise to the somatic, visceral, and cardiac muscle lineages, all of which express D-mef2. tinman is expressed initially in the cardiac and visceral muscle lineages, but ultimately becomes restricted to the dorsal vessel. In D-mef2 mutant embryos, tinman is expressed normally. Formation of somatic muscles is believed to occur by fusion of founder cells with fusion-competent myoblasts. Both of these cell types express D-MEF2. In D-mef2 mutant embryos, nautilus and the homeobox genes S59 and apterous are expressed normally in founder cells, but there is no fusion. Activation of muscle structural genes in all three lineages is dependent on D-MEF2. duced null (Bour et al., 1995) or severe loss-of-function (Ran-MEF2 for their differentiation. Alternatively, D-MEF2 may interact with different sets of cofactors in different somatic ganayakulu et al., 1995) alleles of D-mef2 revealed the partial differentiation of somatic muscle precursors. However, muscle precursors and mutations in the D-MEF2 protein could selectively disrupt interactions with some cofactors an absence of myoblast cell fusion and muscle fiber formation was observed, and a dramatic decrease in the myoblast and not with others, resulting in the absence of specific muscles. Whereas weak alleles of D-mef2 result in selective population followed due to programmed cell death. Such a phenotype is consistent with the ability of the Drosophila ablation of certain somatic muscle fibers, but not others, even relatively weak alleles that have only minor effects embryo to eliminate cells that have failed to complete their normal differentiation program (Abrams et al., 1993) . Inon the somatic musculature completely eliminate certain aspects of the differentiation of cardiac and visceral muscle triguingly, apoptosis is restricted to the somatic muscle population and is not observed in cardiac or visceral muscle cells. This suggests that these muscle cell types are more sensitive to MEF2 activity than somatic muscle cells. One precursors.
Further studies on embryos expressing hypomorphic Dcombination of D-mef2 alleles allows for the occasional survival of transheterozygous mutant adults. These adults mef2 alleles has revealed novel functions of the gene that could not be resolved with complete loss-of-function alleles are flightless and exhibit severe defects in the patterning and organization of the indirect flight muscles present in (Ranganayakulu et al., 1995) . In particular, certain somatic muscles are selectively lost in embryos with partial Dthe thorax. Therefore, D-MEF2 is required for both the larval and adult myogenic programs. D-MEF2 is expressed in MEF2 activity arising from truncated D-MEF2 proteins, indicating that D-mef2 is required for both the formation and adepithelial cells which are the precursors of the adult thoracic muscles. Given the simultaneous expression of Twist patterning of body wall muscle in the Drosophila embryo. This could be explained if the myoblasts that normally form (Bate et al., 1991) and D-MEF2 in these cells, and the recent demonstration of the cooperativity of the myogenic bHLH the muscles that are absent require a higher threshold of D-and MEF2 proteins in regulating skeletal muscle gene extion with other regulatory factors. SRF, for example, interacts with a group of ETS-domain proteins, referred to as pression (Kaushal et al., 1994; Naidu et al., 1995) , Twist and D-MEF2 may interact in the control of gene expression ternary complex factors (TCFs), which bind a site adjacent to the serum response element in the c-fos promoter (Treisin adult muscle differentiation.
Information is emerging on potential targets of D-MEF2 man, 1994) . This interaction is dependent on a region adjacent to the dimerization domain of SRF. DNA binding by transcriptional activity in the different muscle cell lineages. In the cardiac lineage, the dorsal vessel is formed, yet myo-SRF has also been shown to be potentiated by interaction with the homeodomain protein Phox, also called MHox. sin protein is not detected Bour et al., 1995; Ranganayakulu et al., 1995) . The individual mhc, Enhanced DNA binding by SRF in the presence of Phox is believed to occur by acceleration of the on-rate of DNA mlc-alk, and mlc2 subunit genes are not expressed in the dorsal vessel of mutant embryos and thus serve as likely binding (Grueneberg et al., 1992 ). It has not been possible to demonstrate direct physical interaction between SRF and targets of D-MEF2 (Ranganayakulu et al., 1995) . Both genetic and molecular studies implicate the a PS2 integrin subPhox, so it is unclear precisely how this effect is achieved. MCM1 has been shown to regulate cell-type-specific gene unit gene as a target of D-MEF2 in visceral muscle. Null mutations in the inflated locus (Brabant and Brower, 1993;  expression in the budding yeast Saccharomyces cerevisiae through interaction with accessory proteins (Herskowitz, Brown, 1994) , which encodes this integrin subunit, result in an identical midgut phenotype to that observed in D-1989) . The identities of the two haploid cell types in yeast, a and a, require the activation and repression of distinct mef2 mutant embryos. This common phenotype correlates with the lack of aPS2 gene expression and muscle-specific sets of genes. MCM1 controls cell-type-specific genes in yeast by acting in conjunction with two coregulators, a1 enhancer function in the absence of D-mef2 function (Ranganayakulu et al., 1995) . Given the presence of a high-affinand a2, which are expressed only in a cells. In a cells, MCM1 inhibits the expression of a-specific genes by binding ity D-MEF2 site in the a PS2 enhancer, it is probable that this essential integrin subunit gene is a direct target of D-MEF2 their promoters in collaboration with the transcriptional repressor a2. a-Specific genes are activated in the same cells transcriptional activation in visceral muscle.
Future challenges in the study of the D-mef2 gene will by MCM1 in collaboration with the homeodomain protein a1. Neither the a2 repressor nor the a1 activator are present include the analysis of its complex regulation, more detailed studies on its function in the larval and adult myogenic in a cells; a-specific genes are therefore not expressed, even though MCM1 is present. Thus, the response of a gene to programs, and the identification of D-MEF2 target genes. The use of Drosophila genetics will be essential for pre-MCM1 is dictated not simply by the presence of an MCM1 binding site, but also by the sites surrounding that site, as cisely determining the position and function of this MEF2 family member in the genetic hierarchy controlling mesowell as the affinity of MCM1 for that site. MCM1 also mediates the actions of pheromones in yeast, derm differentiation and muscle development. Our current knowledge of the genes and events involved in this complex which act through the cell surface receptors STE2 and STE3. Transcription activation of pheromone-responsive genes is process is summarized in Fig. 5 .
controlled by MCM1 and the transcriptional regulator STE12, which form a complex on the promoters of these
Regulation of Cell-Specific Gene Expression by
genes (Dolan and Fields, 1991) . Activation of pheromone-
MADS Box Proteins
responsive genes leads to cell cycle arrest and morphological changes prior to cell fusion. Expression of the SW15 gene, An important unanswered question is how MEF2 can regulate muscle gene expression in multiple myogenic linwhich encodes a cell-type-specific transcription factor required for mating type switching, is also controlled by eages, which express overlapping but distinct subsets of muscle-specific genes. The mlc-2A gene, for example, is MCM1 (Lydall et al., 1991) . Transcriptional activation of SWI5 by MCM1 is mediated by the cooperative interaction controlled by MEF2 and is expressed in ventricular cardiac myocytes, but not in fast skeletal muscle (Lee et al., 1992) .
of MCM1 with another regulatory protein SFF to form a transcriptional complex on the SWI5 gene control region. Similarly, the myogenin gene is expressed in skeletal, but not in cardiac or smooth muscle cells (Edmondson and The functions of MADS box proteins in regulating cell-typespecific gene expression have also been well characterized . Thus, the ability of MEF2 to activate its target genes must be influenced by a cell's identity or developin plants, in which combinations of MADS box proteins act within a genetic network that establishes floral organ mental history.
In thinking about how MEF2 might regulate muscle gene identity (Weigel and Meyerowitz, 1994) . Given the propensity of MADS box proteins to act combiexpression in multiple muscle cell types, it is useful to consider the mechanisms whereby other MADS box pronatorially with other classes of transactivators, it is tempting to speculate that MEF2 factors may also interact with teins regulate programs of cell-specific gene expression. There are many examples in which MADS box proteins act other regulators to control muscle gene expression. Indeed, MEF2 has been shown to bind DNA cooperatively with at the endpoints of signal transduction pathways to regulate inducible genes and to confer cell identity. In most cases, myogenic bHLH proteins, resulting in synergistic activation of muscle-specific transcription (Funk and Wright, 1992) . MADS box proteins exert these activities through coopera-The possibility that myogenic bHLH proteins influence the pression of the c-jun gene in HeLa cells (Han et al., 1992; Han and Prywes, 1995) . The possibility that MEF2 might activity of MEF2 is suggested by the finding that MEF2A physically interacts with Myogenin and MyoD (Kaushal et confer serum inducibility to certain genes is particularly interesting in light of the role of SRF in the control of musal., 1994) . This interaction is mediated by the MADS box of MEF2A and the basic region and first helix of MyoD.
cle and serum-inducible gene expression (Treisman, 1990) . Perhaps these different MADS domain proteins rely on simMyoD interacts specifically with the MADS box of MEF2 and not with that of SRF. Activation of muscle-specific tranilar mechanisms to control these seemingly disparate forms of gene expression. scription by MyoD is dependent on two residues (alaninethreonine) in the center of the basic region and a third residue (lysine) in the junction between the basic region and
Future Questions
helix-1. Replacement of these residues with the residues at In summary, there is convincing evidence in support of the corresponding positions in E12 abolishes the ability to a role for MEF2 factors in the control of muscle gene expresactivate muscle transcription without affecting DNA bindsion in multiple muscle cell types. However, many iming. Conversely, if these residues are introduced into E12, portant questions remain to be answered. In particular, if they confer the ability to induce myogenesis (Davis and MEF2 controls differentiation of diverse muscle cell types as . MEF2 fails to interact with E12 or with the genetic studies in Drosophila indicate, what determines MyoD mutants lacking the three residues critical for myowhether a cell is skeletal, cardiac, or smooth muscle? We genesis, but it can interact with an E12 mutant containing favor a model in which MEF2 provides a function that is the three myogenic residues (Kaushal et al., 1994) . Thus, the essential for myogenesis in general and in which the addiinteraction between MEF2 and bHLH proteins correlates tional specificity that is unique to each myogenic lineage precisely with myogenic activity. Since myogenic bHLH arises from combinatorial interactions between MEF2 and proteins are not expressed in cardiac or smooth muscle, it other regulators that are restricted to each myogenic linwill be interesting to determine the identities of the factors eage. In skeletal muscle cells, it is likely that MEF2 cooperwith which MEF2 interacts in those cell types to activate ates with myogenic bHLH proteins to establish the skeletal muscle gene expression. muscle phenotype. Whether similar bHLH proteins are exOther factors have also been shown to mediate MEF2-pressed in cardiac and smooth muscle cells remains to be dependent activation of muscle gene expression. A DNA determined, but it is likely that MEF2 has a conserved, binding activity referred to as MAF1, for example, binds a common function in the differentiation of these different MEF3 motif in the aldolase A gene promoter and is required muscle cell lineages. Given the many parallels between for activation of the gene by MEF2 (Hidaka et al., 1993) . muscle and neural differentiation (Jan and Jan, 1993), it will The MEF3 motif is also present in the promoters of the also be interesting to determine whether MEF2 collaborates cardiac troponin C and myogenin genes. Activation of mlcwith neurogenic bHLH factors such as NeuroD (Lee et al., 2 transcription in cardiac myocytes also requires synergism 1995) to regulate neural differentiation. between MEF2 and a ubiquitous factor, HF-1a, which binds MEF2 expression in skeletal muscle cells is also induced an adjacent site in the promoter (Navankasattusas et al., by myogenic bHLH proteins. It will be of interest to deter-1992).
mine the mechanisms that lead to MEF2 expression in other muscle cell types and to determine to what extent the func-
Functions for MEF2 Factors in Addition to Muscle
tions and position of MEF2 in the regulatory pathways lead-
Gene Regulation
ing to muscle formation have been conserved from Drosophila to mammals. In addition to their expression in myogenic lineages, members of the MEF2 family exhibit highly specific expression patterns in the developing brain and appear to demar-ACKNOWLEDGMENTS cate gradients of neuronal maturation. MEF2 gene expression is especially pronounced in the cerebellum, cerebral
